Thyroid Nodules

Terra Swanson


Background

  • ~50% of adults will have a thyroid nodule on ultrasound, 95% are benign.
  • Benign: goiter, cyst, inflammatory, Hashimoto’s, follicular adenoma (microadenoma)
  • Malignant: follicular, papillary, medullary, anaplastic, metastatic, thyroid lymphoma
  • Risk factors for malignancy: age <30, head or neck radiation, family history of thyroid cancer

Evaluation

  • Initial work-up after a nodule is found (either clinically or incidentally on imaging), TSH, Free T4, Thyroid U/S.

Management

  • If Low TSH:
    • Likely a hyperfunctioning nodule (benign in 95% of cases).
    • Order Iodine-123 or technetium-99m thyroid scan.
    • If hyperfunctioning → measure T3/free T4 if ↑, treat for hyperthyroidism.
    • If non-functioning → proceed as if TSH were normal.
  • Normal or elevated TSH:
    • FNA indicated based on U/S findings listed below (ATA guidelines or, more commonly, as determined by TI-RADS system).\Nodules >1cm that have high- or intermediate-suspicion pattern
      • Nodules >1.5cm that have low-suspicion pattern
      • Nodules >2cm that have very-low-suspicion pattern
      • Nodules that do not meet FNA criteria, US findings determine the timing for follow-up imaging (based on most recent ATA guidelines):
        • High suspicion: 6-12mo
        • Low to intermediate suspicion: 12-24mo
        • Nodules >1cm with very ↓ suspicion OR pure cyst: >24mo if at all
        • Nodules <1cm with very ↓ suspicion OR pure cyst: no further imaging necessary.
    • If FNA is obtained, cytology determines the plan of action:
      • Benign → periodic US monitoring at 12-24mo, then at increasing intervals.
      • Indeterminate → repeat FNA with additional sample collected for molecular testing if result is indeterminate again.
      • Malignant → surgical referral.

Last updated on